VANCOUVER’S THE COLUMBIAN–If all goes as planned, the Vancouver-based biotechnology company CytoDyn Inc. will introduce a “game-changing” HIV therapy for sale sometime in 2017.
“We could be commercialized in the first half of 2017,” said Nader Pourhassan, president and CEO of the company, which has seismic ambitions. “This is a very exciting time,” he added.
This is indeed an…
The 2015 Outstanding Staff and Teaching Awards were announced Friday, Aug. 21, representing stellar work by individuals in the University of Utah’s College of Engineering. Dean R[...]